PDB60 COST-EFFECTIVENESS OF LIXISENATIDE COMBINED WITH BASAL INSULIN VERSUS INSULIN REGIMENS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN IN CHINA
May 1, 2019, 00:00
10.1016/j.jval.2019.04.609
https://www.valueinhealthjournal.com/article/S1098-3015(19)30801-0/fulltext
Title :
PDB60 COST-EFFECTIVENESS OF LIXISENATIDE COMBINED WITH BASAL INSULIN VERSUS INSULIN REGIMENS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30801-0&doi=10.1016/j.jval.2019.04.609
First page :
Section Title :
Open access? :
No
Section Order :
10232